Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments
H.L. Bock, Thomas Juretzek, Robert Handreka, Johanna Ruhnau, Madlen Löbel, K. Reuner, Heidrun Peltroche, Alexander Dressel
Topics & Concepts
MedicineImmune systemNatalizumabImmunologyGlatiramer acetateMultiple sclerosisVaccinationCellular immunityHumoral immunityMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 Research